ArticleFrontiers in endocrinology2025
Machine learning-based model for predicting contralateral central lymph node metastasis in papillary thyroid carcinoma with isthmus proximity.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Papillary thyroid carcinoma (PTC) originating from the isthmus exhibits a marked tendency for contralateral central lymph nodes (Cont-CLNs) metastasis. To accurately assess this risk, this study aims to establish and validate an individualized predictive model for contralateral central zone lymph node metastasis in PTC with isthmus proximity using machine learning algorithms. Methods: This retrospective study analyzed 1,672 patients with PTC. Based on tumor location, patients were categorized into a group with PTC with isthmus proximity and a non-isthmic group to compare the incidence of Cont-CLNs metastasis. Subsequently, we focused on 397 patients with PTC with isthmus proximity, who were randomly allocated in a 7:3 ratio to a training set (n=279) and a validation set (n=118). Feature selection was performed using the Boruta algorithm and LASSO regression. Seven machine learning algorithms were then employed to construct prediction models. Model performance was evaluated using metrics including the AUC, sensitivity, and specificity. The optimal model was interpreted using the shapley additive explanations (SHAP) method. Results: This study included 1,672 patients with PTC. The rate of Cont-CLNs metastasis was significantly higher in patients with unilateral PTC with isthmus proximity (n=397) than in those with non-isthmic PTC (33% vs. 12%, Conclusion: The machine learning model developed in this study effectively predicts the risk of Cont-CLNs metastasis in patients with unilateral PTC with isthmus proximity, providing a valuable tool to support personalized surgical decision-making regarding the extent of lymph node dissection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.